Latest Breaking News On - Vistagen therapeutics - Page 2 : comparemela.com

VistaGen Therapeutics, Inc (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript

VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.31.

Andrew tsaiMark mcpartlandPaul matisseShawn singhJosh princeCindy andersonVistagen therapeutics incChocolate companiesVistagen therapeuticsCall transcript februaryGen therapeuticsVistagen therapeutic fiscal yearQuarter financial resultsSenior vice presidentInvestor relationsChief executive officer

Earnings Scheduled For February 13, 2024 - Agree Realty (NYSE:ADC), Airbnb (NASDAQ:ABNB)

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

United statesCharles colvardKrispy kremeCommunity healthcareEversource energyHyatt hotelsVector groupInventrust propertiesGreenpower motor coHyliion holdingsLeidos holdingsRoivant sciencesRush enterprisesHowmet aerospaceTigo energyNational research

VistaGen Therapeutics (VTGN) Files $350M Mixed Shelf

VistaGen Therapeutics (VTGN) Files $350M Mixed Shelf
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vistagen therapeutics

VistaGen Therapeutics (VTGN) Files $350M Mixed Shelf

Vistagen therapeutics

VistaGen Therapeutics (VTGN) Misses Q3 EPS by 22c

VistaGen Therapeutics (VTGN) Misses Q3 EPS by 22c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vistagen therapeutics